cd49d antibody, anti-mouse (Miltenyi Biotec)
Structured Review
Cd49d Antibody, Anti Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 34 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd49d/CD49d+Antibody%2C+anti-mouse/custom%40130-121-444%4042385703
Average 92 stars, based on 34 article reviews
Images
Related Articles
Flow Cytometry:Article Title: Residual homing of α4β7-expressing β1 + PI16 + regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Article Snippet: .. Flow cytometry was performed according to standard protocols using the following fluorochrome- conjugated extracellular antibodies: CD3 (VioGreen, REA613, Miltenyi Biotec), CD4 (FITC/VioBlue/VioGreen/APC- Vio770, VIT4, Miltenyi Biotec), CD45RO (BV510, UCHL1, Biolegend), CD25 (PE/Cy7, BC96, Biolegend), CD127 (APC- Vio770/VioBright FITC, REA614, Miltenyi Biotec; APC, A019D5, Biolegend), Article Title: Engineering therapeutic T regs to overexpress GPR15 improves functional fitness for in vivo gut homing. Article Snippet: .. Flow cytometry Jo urn al Pr e-p roo f To analyze GPR15 and a4b7 integrin expression engineered Tregs were stained with Fixable Viability Dye efluor506 (Invitrogen) for 30 minutes at 4°C, washed once with PBS and stained with the following antibodies for 15 minutes at 4°C: CD25 (APC/Cy7, A251, Biolegend), CD127 (APC, A019D5, Biolegend), Article Title: Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Article Snippet: From the *Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany †Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Germany Address correspondence to: Sebastian Zundler, MD, PhD, Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg, Ulmenweg 18, D-91054 Erlangen, Germany (sebastian.zundler@uk-erlangen.de). Recombinase Polymerase Amplification:Article Title: Residual homing of α4β7-expressing β1 + PI16 + regulatory T cells with potent suppressive activity correlates with exposure-efficacy of vedolizumab. Article Snippet: .. Flow cytometry was performed according to standard protocols using the following fluorochrome- conjugated extracellular antibodies: CD3 (VioGreen, REA613, Miltenyi Biotec), CD4 (FITC/VioBlue/VioGreen/APC- Vio770, VIT4, Miltenyi Biotec), CD45RO (BV510, UCHL1, Biolegend), CD25 (PE/Cy7, BC96, Biolegend), CD127 (APC- Vio770/VioBright FITC, REA614, Miltenyi Biotec; APC, A019D5, Biolegend), Expressing:Article Title: Engineering therapeutic T regs to overexpress GPR15 improves functional fitness for in vivo gut homing. Article Snippet: .. Flow cytometry Jo urn al Pr e-p roo f To analyze GPR15 and a4b7 integrin expression engineered Tregs were stained with Fixable Viability Dye efluor506 (Invitrogen) for 30 minutes at 4°C, washed once with PBS and stained with the following antibodies for 15 minutes at 4°C: CD25 (APC/Cy7, A251, Biolegend), CD127 (APC, A019D5, Biolegend), Staining:Article Title: Engineering therapeutic T regs to overexpress GPR15 improves functional fitness for in vivo gut homing. Article Snippet: .. Flow cytometry Jo urn al Pr e-p roo f To analyze GPR15 and a4b7 integrin expression engineered Tregs were stained with Fixable Viability Dye efluor506 (Invitrogen) for 30 minutes at 4°C, washed once with PBS and stained with the following antibodies for 15 minutes at 4°C: CD25 (APC/Cy7, A251, Biolegend), CD127 (APC, A019D5, Biolegend), Article Title: Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Article Snippet: From the *Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany †Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Germany Address correspondence to: Sebastian Zundler, MD, PhD, Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg, Ulmenweg 18, D-91054 Erlangen, Germany (sebastian.zundler@uk-erlangen.de). Article Title: Flow cytometric immunophenotypic differentiation patterns of bone marrow eosinophilopoiesis. Article Snippet: For surface immunostaining, bone marrow aspirates or peripheral blood were lysed using FACS lysing buffer (BD Bioscience) and cells were washed twice with 1% albumin in PBS. .. Cells were then stained using directly-conjugated antibodies against CD9, CD11b,CD13, CD34, CD38, CD69, CD44, Blocking Assay:Article Title: Etrolizumab-s Does Not Induce Residual Trafficking of Regulatory T Cells. Article Snippet: From the *Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany †Deutsches Zentrum Immuntherapie (DZI), University Hospital Erlangen, Germany Address correspondence to: Sebastian Zundler, MD, PhD, Department of Medicine 1, University Hospital Erlangen, Friedrich-Alexander-Universität ErlangenNürnberg, Ulmenweg 18, D-91054 Erlangen, Germany (sebastian.zundler@uk-erlangen.de). Selection:Article Title: Myeloperoxidase-dependent tyrosine halogenation potentiates α-defensins functions Article Snippet: Subsequently, neutrophils were purified by an in-house negative selection kit based on a modified mouse-neutrophil positive selection kit EasySep (Stemcell Technologies). .. The antibodies used for the negative selection were: mouse ant-rat CD32 (Becton Dickinson), mouse anti-rat-Ly76 (Miltenyi Biotech), APC conjugated mouse anti-rat antibodies: MHC class II, CD3, CD31, CD4, CD45RC, Immunopeptidomics:Article Title: Myeloperoxidase-dependent tyrosine halogenation potentiates α-defensins functions Article Snippet: Subsequently, neutrophils were purified by an in-house negative selection kit based on a modified mouse-neutrophil positive selection kit EasySep (Stemcell Technologies). .. The antibodies used for the negative selection were: mouse ant-rat CD32 (Becton Dickinson), mouse anti-rat-Ly76 (Miltenyi Biotech), APC conjugated mouse anti-rat antibodies: MHC class II, CD3, CD31, CD4, CD45RC, |
